Jin Medical International Ltd. (ZJYL)
Healthcare
- Fundamental
- 2
- Sentiment
- 3
- Technical
- 4
Do Nothing: fundamentalScore is 2 (below required floor of 3); additionally, the max overnight gap is 62.33%, above the 5% limit, so the protective stop is unprotectable.
Company overview
Jin Medical International Ltd. designs, manufactures, and distributes mobility aids, such as wheelchairs, oxygen concentrators, and bathing devices, for individuals with limited mobility. Founded in 2006, the company is based in Changzhou, China, and is a subsidiary of Jolly Harmony Enterprises Limited.
Fundamental
weakZJYL's fundamentals show elevated risk due to declining profitability and negative cash flow.
ZJYL has decent liquidity but weakening operating momentum: FY2025 revenue fell ~12% and margins compressed sharply, and the first half of FY2026 showed a small net loss with negative operating cash flow. With PRC/VIE and customer-concentration risk plus low-float/high-volatility trading characteristics and negative free-cash-flow yield, the fundamentals skew to elevated risk rather than an attractive near-term opportunity (fundamentalScore 2/5).
Sentiment
fairSentiment is mixed with speculative trading interest but no clear forward catalysts.
ZJYL’s near-term narrative is conflicted: recent FY2026 1H results and headlines around a very large share issuance/VIE-control transaction skew bearish, while media/retail attention remains focused on volatility and momentum. 14‑day media sentiment is essentially flat-to-slightly higher versus the 30–90d baseline; moderate red flags (promotion chatter and conflicting momentum vs dilution/regulatory headlines) cap the setup at 3.
Technical
goodTechnical indicators suggest a bullish short-term trend but with high volatility and gap risk.
Score 4: trend, momentum, and volume all improved sharply - price is above key moving averages, MACD has crossed above both signal and zero, and turnover exploded. It is not a 5 because the breakout is stretched and gap-driven, with an intraday fade below VWAP that weakens follow-through quality.
You’re looking at 2026-08-10 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.